<- Go Home
ST Pharm Co.,Ltd.
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
Market Cap
KRW 1.9T
Volume
191.1K
Cash and Equivalents
KRW 53.8B
EBITDA
KRW 104.6B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 151.5B
Profit Margin
39.19%
52 Week High
KRW 172.1K
52 Week Low
KRW 84.1K
Dividend
N/A
Price / Book Value
3.09
Price / Earnings
25.60
Price / Tangible Book Value
3.18
Enterprise Value
KRW 1.9T
Enterprise Value / EBITDA
17.70
Operating Income
KRW 70.8B
Return on Equity
13.61%
Return on Assets
5.60
Cash and Short Term Investments
KRW 170.4B
Debt
KRW 74.8B
Equity
KRW 629.1B
Revenue
KRW 386.5B
Unlevered FCF
KRW 45.0B
Sector
Pharmaceuticals
Category
N/A